OTC Markets EXMKT - Delayed Quote USD
Spencer Pharmaceutical Inc. (SPPH)
0.0001
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
Breakdown
TTM
Operating Expense
1,313.4970
Operating Income
-1,223.4140
Pretax Income
-1,237.4260
Net Income Common Stockholders
-1,237.4260
Diluted NI Available to Com Stockholders
-1,237.4260
Basic EPS
-1.25
Diluted EPS
-1.25
Basic Average Shares
920.4300
Diluted Average Shares
920.4300
Total Operating Income as Reported
1,223.4140
Total Expenses
1,893.6280
Net Income from Continuing & Discontinued Operation
-1,237.4260
Normalized Income
-1,237.4260
EBIT
-1,223.4140
EBITDA
-1,223.4140
Net Income from Continuing Operation Net Minority Interest
-1,237.4260
Normalized EBITDA
-1,223.4140
Tax Rate for Calcs
0
Tax Effect of Unusual Items
0
8/21/57328 - 10/6/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHGE BiomX Inc.
0.5160
-7.38%
CHRO Channel Therapeutics Corporation
1.1000
-1.79%
ACXP Acurx Pharmaceuticals, Inc.
0.3600
-4.79%
CLGN CollPlant Biotechnologies Ltd.
1.8200
-0.55%
PHRRF PharmaTher Holdings Ltd.
0.1570
+3.09%
TNFA TNF Pharmaceuticals, Inc.
0.1900
-3.36%
PEPG PepGen Inc.
1.5000
-2.60%
CGTX Cognition Therapeutics, Inc.
0.3011
-8.76%
INZY Inozyme Pharma, Inc.
1.1500
-7.26%
ALZN Alzamend Neuro, Inc.
0.6581
+21.87%